These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4924649)

  • 1. A double-blind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis.
    Devadatta S; Menon NK; Nazareth O; Radhakrishna S; Ramakrishnan CV; Somasundaram PR; Usha SP; Velu S
    Tubercle; 1970 Sep; 51(3):263-9. PubMed ID: 4924649
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the clinical usefulness of ethionamide and prothionamide in initial treatment of tuberculosis: tenth series of controlled trials.
    Tubercle; 1968 Sep; 49(3):281-90. PubMed ID: 4884773
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of resistant pulmonary tuberculosis in Hong Kong with regimens of second-line drugs.
    Horsfall PA
    Tubercle; 1972 Sep; 53(3):166-73. PubMed ID: 4116994
    [No Abstract]   [Full Text] [Related]  

  • 4. Capreomycin-ethionamide as a retreatment regimen for pulmonary tuberculosis.
    Schless JM; Allison RF; Inglis RM; Topperman S; Trapp E
    Ann N Y Acad Sci; 1966 Apr; 135(2):1085-97. PubMed ID: 5328002
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute hepatic necrosis associated with ethionamide.
    Hollinrake K
    Br J Dis Chest; 1968 Jul; 62(3):151-4. PubMed ID: 5667591
    [No Abstract]   [Full Text] [Related]  

  • 6. A study of acute intolerance to ethionamide, including a comparison with prothionamide, and of the influence of a vitamin B-complex additive in prophylaxis.
    Fox W; Robinson DK; Tall R; Kent PW; Macfadyen DM
    Tubercle; 1969 Jun; 50(2):125-43. PubMed ID: 4894707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS; Bialik IB
    Probl Tuberk; 1969; 47(6):23-8. PubMed ID: 4311969
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of second line drugs in patients with drug resistance to standard tuberculostatics.
    Zierski M
    Dis Chest; 1968 Apr; 53(4):421-6. PubMed ID: 5652478
    [No Abstract]   [Full Text] [Related]  

  • 10. General considerations in intermittent drug therapy of pulmonary tuberculosis.
    Fox W
    Postgrad Med J; 1971 Nov; 47(553):729-36. PubMed ID: 4110537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatotoxic effect of ethionamide and para-amino-salicylic acid in initial chemotherapy of patients with pulmonary tuberculosis in the light of liver function tests].
    Pruszyńska S
    Gruzlica; 1971 Dec; 39(12):1211-8. PubMed ID: 5139240
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the administration of ethionamide-chlorhydrate in pulmonary tuberculosis and meningeal tuberculosis].
    Schrádi A; Bene J; Szabó A; Molnár E
    Z Tuberk Erkr Thoraxorg; 1968 Mar; 127(5):307-11. PubMed ID: 5755348
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
    Bartal M; Nejjar A; Laraki A
    Tunis Med; 1973 Jul; 51(4):237-43. PubMed ID: 4209977
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early and late results of massive antitubercular chemotherapy in previously untreated pulmonary tuberculosis in adults].
    Sosnowski W; Kubiak Z
    Gruzlica; 1972 Jan; 40(1):21-8. PubMed ID: 5011722
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of drug resistant chronic pulmonary tuberculosis with a number of tuberculostatics].
    Bernard E
    Bull Int Union Tuberc; 1968 Dec; 41():183-7. PubMed ID: 4303862
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early results of a modified treatment of 100 cases of newly detected tuberculosis with standard drugs with the substitution of PAS for ethionamide].
    Piekarniak K; Danilczuk R; Martyniak K; Wyczółkowski M
    Gruzlica; 1973 Aug; 41(8):837-43. PubMed ID: 4755391
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cheotherapy of chronic pulmonary tuberculosis with resistant mycobacteria].
    Fegiz G
    Policlinico Prat; 1967 Oct; 74(43):1454-62. PubMed ID: 5629122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy with PAS, rifamycin and ethionamide administered intravenously and its effects on glucide metabolism in diabetics affected by pulmonary tuberculosis].
    Filla E; Comenale D
    Minerva Med; 1965 Dec; 56(103):4570-3. PubMed ID: 5858896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.